NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.990
-0.125 (-11.20%)
At close: Nov 20, 2024, 4:00 PM
1.000
+0.010 (1.00%)
After-hours: Nov 20, 2024, 5:46 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $19.28 million as of November 21, 2024. Its market cap has increased by 153.15% in one year.
Market Cap
19.28M
Enterprise Value
18.11M
1-Year Change
153.15%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $19.28M, a decrease of -70.16%. That is a compound annual growth rate of -33.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 21.71M | 102.37% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuronetics | 22.92M |
| Lisata Therapeutics | 22.88M |
| Cadrenal Therapeutics | 22.65M |
| NEXGEL | 22.06M |
| Enlivex Therapeutics | 22.05M |
| Bionano Genomics | 21.53M |
| Bolt Biotherapeutics | 21.47M |
| XTL Biopharmaceuticals | 21.45M |